ArticleBritish journal of pharmacology2015

Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.

F Cerrato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.